These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 7215442

  • 1. Kainate lesion dissociates striatal dopamine receptor radioligand binding sites.
    Leff S, Adams L, Hyttel J, Creese I.
    Eur J Pharmacol; 1981 Mar 05; 70(1):71-5. PubMed ID: 7215442
    [Abstract] [Full Text] [Related]

  • 2. Kainic acid lesions dissociate [3H] spiperone and [3H]cis-flupenthixol binding sites in rat striatum.
    Cross AJ, Waddington JL.
    Eur J Pharmacol; 1981 May 08; 71(2-3):327-32. PubMed ID: 7250192
    [Abstract] [Full Text] [Related]

  • 3. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
    Leff SE, Creese I.
    Mol Pharmacol; 1985 Feb 08; 27(2):184-92. PubMed ID: 3969067
    [Abstract] [Full Text] [Related]

  • 4. Differential anatomical location of [3H]-N,n-propylnorapomorphine and [3H]-spiperone binding sites in the striatum and substantia nigra of the rat.
    Hall MD, Jenner P, Kelly E, Marsden CD.
    Br J Pharmacol; 1983 Jun 08; 79(2):599-610. PubMed ID: 6418246
    [Abstract] [Full Text] [Related]

  • 5. Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes.
    Hamblin MW, Leff SE, Creese I.
    Biochem Pharmacol; 1984 Mar 15; 33(6):877-87. PubMed ID: 6712712
    [Abstract] [Full Text] [Related]

  • 6. Effect of kainic acid on striatal dopamine receptors.
    Weinreich P, Seeman P.
    Brain Res; 1980 Oct 06; 198(2):491-6. PubMed ID: 7407614
    [No Abstract] [Full Text] [Related]

  • 7. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
    Lazareno S, Nahorski SR.
    Eur J Pharmacol; 1982 Jul 09; 81(2):273-85. PubMed ID: 7117377
    [Abstract] [Full Text] [Related]

  • 8. In vivo binding of N-n-propylnorapomorphine in the rat striatum: quantification after lesions produced by kainate, 6-hydroxydopamine and decortication.
    Van der Werf JF, Sebens JB, Korf J.
    Eur J Pharmacol; 1984 Jul 13; 102(2):251-9. PubMed ID: 6434329
    [Abstract] [Full Text] [Related]

  • 9. Localization of [3H]N-propylnorapomorphine binding in mouse striatum.
    Severson JA, Randall PK.
    Brain Res; 1983 Nov 21; 279(1-2):295-8. PubMed ID: 6416612
    [Abstract] [Full Text] [Related]

  • 10. Turnover of specific [3H]spiperone and [3H]N,n-propylnorapomorphine binding sites in rat striatum following phenoxybenzamine administration.
    Hall MD, Jenner P, Marsden CD.
    Biochem Pharmacol; 1983 Oct 01; 32(19):2973-7. PubMed ID: 6626267
    [Abstract] [Full Text] [Related]

  • 11. Interaction of the putative dopamine autoreceptor agonists 3-PPP and TL-99 with [3H]apomorphine binding sites in rat striatal membranes.
    Williams M, Totaro JA.
    Eur J Pharmacol; 1982 Dec 17; 86(1):35-42. PubMed ID: 7160432
    [Abstract] [Full Text] [Related]

  • 12. In situ molecular size of agonist dopamine D-2 binding sites in rat striatum.
    Gredal O, Nielsen M.
    J Neurochem; 1987 Feb 17; 48(2):364-9. PubMed ID: 3794711
    [Abstract] [Full Text] [Related]

  • 13. Interaction of L-prolyl-L-leucyl glycinamide with dopamine D2 receptor: evidence for modulation of agonist affinity states in bovine striatal membranes.
    Srivastava LK, Bajwa SB, Johnson RL, Mishra RK.
    J Neurochem; 1988 Mar 17; 50(3):960-8. PubMed ID: 2892892
    [Abstract] [Full Text] [Related]

  • 14. Characterization of normal and supersensitive dopamine receptors: effects of ergot drugs and neuropeptides.
    Fuxe K, Agnati LF, Köhler C, Kuonen D, Ogren SO, Andersson K, Hökfelt T.
    J Neural Transm; 1981 Mar 17; 51(1-2):3-37. PubMed ID: 7264628
    [Abstract] [Full Text] [Related]

  • 15. Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatum.
    Hess EJ, Battaglia G, Norman AB, Iorio LC, Creese I.
    Eur J Pharmacol; 1986 Feb 11; 121(1):31-8. PubMed ID: 2869957
    [Abstract] [Full Text] [Related]

  • 16. Quantification of in vivo spiperone binding in the rat striatum after lesions produced by kainate or decortication.
    Van der Werf JF, Van het Schip F, Sebens JB, Korf J.
    Eur J Pharmacol; 1984 Jul 20; 102(3-4):387-99. PubMed ID: 6436037
    [Abstract] [Full Text] [Related]

  • 17. Binding of [3H]apomorphine to striatal membranes prepared from rat brain after 6-hydroxydopamine and kainic acid lesions.
    Fujita N, Saito K, Iwatsubo K, Hirata A, Noguchi Y, Yoshida H.
    Brain Res; 1980 May 26; 190(2):593-6. PubMed ID: 7370810
    [No Abstract] [Full Text] [Related]

  • 18. The binding of [3H]N-(chloroethyl)-norapomorphine to rat striatal membranes.
    Kilpatrick GJ, Jenner P, Marsden CD.
    Eur J Pharmacol; 1984 Dec 15; 107(1):71-8. PubMed ID: 6084599
    [Abstract] [Full Text] [Related]

  • 19. Chronic haloperidol does not alter agonist affinity for dopamine receptors in vitro.
    Meller E, Bohmaker K, Goldstein M, Schweitzer JW, Friedhoff AJ.
    Eur J Pharmacol; 1985 Mar 12; 109(3):389-94. PubMed ID: 3157587
    [Abstract] [Full Text] [Related]

  • 20. Interactions of dopamine agonists with brain D1 receptors labeled by 3H-antagonists. Evidence for the presence of high and low affinity agonist-binding states.
    Leff SE, Hamblin MW, Creese I.
    Mol Pharmacol; 1985 Feb 12; 27(2):171-83. PubMed ID: 3969066
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.